4 Essentials to Lead the Digital Health Race in Ophthalmology

At 52, Anya experienced frequent episodes of blurred vision. Her ophthalmologist suspected that her vision problems might be due to refractive error, which is a common condition that causes blurry vision and is often correctable with glasses or contact lenses. Since Anya's busy work schedule made it challenging for her to visit her ophthalmologist regularly, her ophthalmologist recommended a telemedicine consultation using a mobile app that had a digital imaging tool. This allowed Anya to capture and share images of her eyes with her doctor. Built-in technology, like Software as a medical device (SaMD) and AI algorithms, helped detect subtle changes in her retina, providing crucial information about her eye health and potential risks. This allowed her doctor to quickly develop an effective plan to correct her vision. Anya now uses the app to monitor her eye health, make adjustments to her contact lenses, and catch complications earlier, leading to better vision control.

Such success stories are driving patients' interest in remote, technology-enabled health management platforms such as Luna, Eyecare Live, Advanced Ophthalmic Systems, and Optos. This momentum in the digital health race in ophthalmology is creating innumerable growth avenues for organizations, which include:

Therefore, it is not a surprise that the SaMD market is estimated to grow at an annual growth rate of 22% by 2027. This, in turn, will attract more players, and the competition among emerging ophthalmology startups and established players, as well as strategic partnerships and collaborations, will only continue to intensify within the advanced ophthalmology technologies market.

What do companies need to stay ahead? To capitalize on the opportunities presented by the broader digital health race in ophthalmology, it is important for business leaders to stay on top of best practices. We highlight a few critical ones below.

As life sciences companies strive to lead the digital health race in ophthalmology, it is crucial for them to stay on top of the varying regulatory policies surrounding SaMDs. In addition, companies must pay attention to important design, coding standards, and cybersecurity considerations to protect sensitive patient information. We briefly discuss this below.

The US Food and Drug Administration (FDA) has outlined the requirements for clinical evaluation and software validation of SaMDs. To promote seamless integration with other medical devices and health IT systems, the FDA recommends that SaMDs be designed to be interoperable.

SaMD manufacturers must also comply with US privacy and data protection laws, such as the Health Insurance Portability and Accountability Act (HIPAA), to ensure that their products are secure and any Personal Identifiable Information (PII) is protected.

Furthermore, the FDA has issued guidelines on cybersecurity considerations for SaMDs, which include recommendations for secure coding practices, vulnerability testing, and risk management.

SaMD products are subject to strict regulations under the Medical Device Regulation (MDR). Before they can be marketed, these products must undergo a thorough conformity assessment to ensure that they meet safety and performance requirements, as well as other requirements such as clinical evaluation and post-market surveillance.

Manufacturers must also comply with the General Data Protection Regulation (GDPR) and other relevant data protection laws to protect patient data.

In addition, coding standards for SaMD are considered an essential requirement of the MDR, and must comply with relevant harmonized standards. The MDR framework requires manufacturers to document their use of coding standards in the technical documentation for their product and assess their suitability for a given SaMD.

B2B2C/e-commerce strategies involve selling directly to businesses (B2B) that then sell the products to end consumers (B2C) through online platforms. This strategy can help companies reach a large customer base by leveraging the customer network of their partner businesses. Companies can also leverage their partner's resources and expertise. Take ecommerce for instance. E-commerce platforms enable convenience and seamless customer experiences, leading to higher customer satisfaction and repeat business.

For example: A digital health company that provides telemedicine services and medical devices for ophthalmology could partner with an e-commerce platform to reach new customers and provide a seamless online buying experience. Additionally, the company could partner with ophthalmology clinics and hospitals to expand its network of providers and further penetrate the market. This way, the company can leverage both online and offline channels to reach and serve its customers better.

In the case of remote eye care, companies that offer both platforms and applications with integrated AI technologies can be particularly competitive. These companies can leverage AI to streamline the diagnostic process, enabling more efficient and accurate assessments of eye health. They can also offer a more seamless user experience by integrating their platform with their application, allowing patients to easily access their eye care information and communicate with their healthcare provider conveniently.

Leading the Digital Health Race in Ophthalmology